PTHS — PELTHOS THERAPEUTICS INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 23 SEC-registered investment managers reported holding PTHS (PELTHOS THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $37.53M across 1.33M shares. That is +2.0% by share count (+18.38K shares) versus the previous quarter, while reported value moved +37.2%. Ownership is concentrated: the five largest holders account for 82.0% of reported value and the top ten for 93.0%.
Compared with the prior quarter, 9 opened new positions, 6 added to existing stakes, 3 trimmed, 3 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of PELTHOS THERAPEUTICS INC (PTHS) include Ikarian Capital, LLC, Murchinson Ltd., AIGH Capital Management LLC, ranked by reported 13F value among the 36 institutional holders on this page.
PTHS is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 19 | 860.49K | $18.08M | +1.1% |
| Q2 2026 | 23 | 1.33M | $37.53M | +2.0% |
| Q1 2026 | 17 | 912.31K | $19.17M | -0.5% |
| Q4 2025 | 16 | 910.42K | $28.22M | +66.1% |
| Q3 2025 | 14 | 462.76K | $12.96M | — |
Over the 5 quarters shown, institutional share counts increased 86% in aggregate (Q3 2025 → Q3 2026); the largest single-quarter swing was Q4 2025 (+66.1%).
Top Institutional Holders (Q3 2026) — 19 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 311.02K | $6.53M | 1.25% | Add | |
| 256.01K | $5.38M | 0.54% | Reduce | |
| 95.32K | $2.00M | 0.00% | Reduce | |
| 84.62K | $1.78M | 0.23% | Add | |
| 20.23K | $424.99K | 0.16% | Add | |
| 17.64K | $370.70K | 0.20% | Reduce | |
| 16.57K | $348.24K | 0.00% | Add | |
| 14.58K | $306.26K | 0.10% | Add | |
| 12.92K | $271.43K | 0.02% | Hold | |
| 10.80K | $226.91K | 0.00% | New | |
| 10.36K | $217.73K | 0.00% | Add | |
| 5.09K | $107.00K | 0.00% | Reduce | |
| 2.36K | $49.37K | 0.00% | Add | |
| 1.37K | $28.78K | 0.00% | New | |
| 1.22K | $25.72K | 0.00% | Reduce | |
| 326 | $6.82K | 0.00% | New | |
| 40 | $840 | 0.00% | Hold | |
| 6 | $126 | 0.00% | New | |
| 5 | $105 | 0.00% | New |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 23 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 329.10K | $9.30M | 0.59% | New | |
| 304.30K | $8.60M | 2.32% | Add | |
| 256.60K | $7.25M | 1.17% | Hold | |
| 101.98K | $2.88M | 0.06% | Add | |
| 97.13K | $2.75M | 0.00% | Add | |
| 38.12K | $1.08M | 0.03% | Reduce | |
| 38.08K | $1.08M | 0.04% | Reduce | |
| 24.77K | $700.09K | 0.15% | Hold | |
| 22.36K | $632.01K | 0.08% | New | |
| 22.07K | $623.78K | 0.33% | Add | |
| 15.05K | $425.20K | 0.00% | New | |
| 14.65K | $414.01K | 0.00% | New | |
| 14.65K | $414.01K | 0.00% | Reduce | |
| 12.92K | $365.09K | 0.03% | Hold | |
| 10.38K | $293.34K | 0.09% | New | |
| 9.87K | $279.01K | 0.00% | Add | |
| 6.01K | $169.76K | 0.07% | Hold | |
| 5.32K | $150.46K | 0.00% | New | |
| 2.22K | $62.65K | 0.00% | Add | |
| 2.16K | $61.04K | 0.00% | New | |
| 205 | $5.79K | 0.00% | New | |
| 40 | $1.13K | 0.00% | Hold | |
| 20 | $565 | 0.00% | New |
Q1 2026 — 17 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 296.31K | $6.23M | 2.03% | Add | |
| 256.60K | $5.39M | 0.66% | Hold | |
| 93.09K | $1.96M | 0.00% | New | |
| 81.86K | $1.72M | 0.04% | Add | |
| 50.41K | $1.06M | 0.06% | Reduce | |
| 41.42K | $870.30K | 0.04% | Add | |
| 24.77K | $520.48K | 0.18% | Reduce | |
| 21.07K | $442.74K | 0.27% | Add | |
| 15.29K | $321.24K | 0.00% | Add | |
| 12.92K | $271.43K | 0.02% | Add | |
| 9.82K | $206.25K | 0.00% | New | |
| 6.01K | $126.21K | 0.06% | Hold | |
| 1.91K | $40.13K | 0.00% | Hold | |
| 764 | $16.05K | 0.00% | Add | |
| 40 | $852 | 0.00% | New | |
| 16 | $336 | 0.00% | New | |
| 1 | $21 | 0.00% | New |
Q4 2025 — 16 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 289.48K | $8.97M | 2.62% | Add | |
| 255.76K | $7.93M | 0.92% | Add | |
| 80.68K | $2.50M | 0.07% | Add | |
| 78.01K | $2.42M | 0.11% | New | |
| 75.02K | $2.33M | 0.00% | Add | |
| 34.99K | $1.08M | 0.04% | New | |
| 25.00K | $775.00K | 0.20% | Add | |
| 19.28K | $597.71K | 0.28% | Add | |
| 13.62K | $422.38K | 0.00% | Add | |
| 11.06K | $342.77K | 0.00% | New | |
| 11.06K | $342.77K | 0.00% | New | |
| 8.10K | $251.10K | 0.02% | New | |
| 6.01K | $186.22K | 0.10% | Add | |
| 1.91K | $59.21K | 0.00% | Hold | |
| 434 | $13.45K | 0.00% | Add | |
| 12 | $372 | 0.00% | Add |
Q3 2025 — 14 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 280.00K | $7.84M | 1.94% | New | |
| 66.84K | $1.87M | 0.00% | New | |
| 62.45K | $1.75M | 0.28% | New | |
| 21.25K | $594.86K | 0.01% | New | |
| 10.50K | $293.94K | 0.11% | New | |
| 10.33K | $289.24K | 0.00% | New | |
| 6.11K | $171.14K | 0.07% | New | |
| 2.40K | $67.28K | 0.05% | New | |
| 1.91K | $53.48K | 0.00% | New | |
| 827 | $23.16K | 0.00% | New | |
| 137 | $3.84K | 0.00% | New | |
| 11 | $308 | 0.00% | New | |
| 1 | $28 | 0.00% | New | |
| 1 | $28 | 0.00% | New |
New Positions (Q2 2026)
- AIGH Capital Management LLC 329.10K sh · $9.30M
- WEXFORD CAPITAL LP 22.36K sh · $632.01K
- Citadel Advisors 15.05K sh · $425.20K
- GEODE CAPITAL MANAGEMENT, LLC 14.65K sh · $414.01K
- 1492 Capital Management LLC 10.38K sh · $293.34K
- BlackRock Inc 5.32K sh · $150.46K
- China Universal Asset Management Co., Ltd. 2.16K sh · $61.04K
- Tower Research Capital LLC (TRC) 205 sh · $5.79K
- BARCLAYS PLC 20 sh · $565
Fully Exited (vs previous quarter)
- Steward Partners Investment Advisory, LLC sold 1.91K sh · $40.13K
- Aspect Partners, LLC sold 16 sh · $336
- Citigroup Inc sold 1 sh · $21
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Murchinson Ltd. | 311.02K | 304.30K | 296.31K | 289.48K | 280.00K |
| AIGH Capital Management LLC | 256.01K | 329.10K | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 95.32K | 97.13K | 93.09K | — | — |
| WEXFORD CAPITAL LP | 84.62K | 22.36K | — | — | — |
| Persistent Asset Partners Ltd | 20.23K | 6.01K | 6.01K | 6.01K | 2.40K |
| Knott David M Jr | 17.64K | 22.07K | 21.07K | 19.28K | 6.11K |
| Geode Capital Management | 16.57K | 14.65K | 15.29K | 13.62K | 10.33K |
| 1492 Capital Management LLC | 14.58K | 10.38K | — | — | — |
| Pale Fire Capital SE | 12.92K | 12.92K | 12.92K | 8.10K | — |
| STATE STREET CORP | 10.80K | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 10.36K | 9.87K | 9.82K | — | — |
| BlackRock Inc | 5.09K | 5.32K | — | — | — |
| China Universal Asset Management Co., Ltd. | 2.36K | 2.16K | — | — | — |
| Vanguard Global Advisers, LLC | 1.37K | — | — | — | — |
| UBS Group AG | 1.22K | 2.22K | 764 | 434 | 137 |
| Nuveen, LLC | 326 | — | — | — | — |
| Farther Finance Advisors, LLC | 40 | 40 | 40 | — | — |
| Morgan Stanley | 6 | — | — | — | — |
| Parallel Advisors, LLC | 5 | — | — | — | — |
| Ikarian Capital, LLC | — | 256.60K | 256.60K | 255.76K | 62.45K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold PTHS?
As of 2026-Q2, 23 institutional funds reported holding PTHS (PELTHOS THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $37.53M.
How many shares of PTHS do institutions own?
13F filers reported 1.33M shares of PTHS, worth $37.53M in aggregate at the end of 2026-Q2.
Is institutional ownership of PTHS rising or falling?
Share counts moved +2.0% versus the prior quarter — accumulation.
Who are the top institutional holders of PTHS?
The largest 13F holders are Ikarian Capital, LLC, Murchinson Ltd., AIGH Capital Management LLC, BOOTHBAY FUND MANAGEMENT, LLC, Vanguard Group; the top 25 are ranked at the top of this page.
Who are the major shareholders of PELTHOS THERAPEUTICS INC?
The major shareholders of PELTHOS THERAPEUTICS INC (PTHS) by reported 13F value are Ikarian Capital, LLC, Murchinson Ltd., AIGH Capital Management LLC, BOOTHBAY FUND MANAGEMENT, LLC, Vanguard Group, among 36 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.